Header Logo

Connection

BILAL OMER to Cell- and Tissue-Based Therapy

Back to Details
This is a "connection" page, showing publications BILAL OMER has written about Cell- and Tissue-Based Therapy.
BILAL OMER
Connection Strength
0.695
Cell- and Tissue-Based Therapy
  1. Posoleucel, an Allogeneic, Off-the-Shelf Multivirus-Specific T-Cell Therapy, for the Treatment of Refractory Viral Infections in the Post-HCT Setting. Clin Cancer Res. 2023 01 17; 29(2):324-330.
    View in: PubMed
    Score: 0.695
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.